510(k) K252296

OncoPatch by Oncopatch, Inc. — Product Code KXK

K252296 is an FDA 510(k) premarket notification submitted by Oncopatch, Inc. for the device "OncoPatch". The FDA issued a decision of Substantially Equivalent on Dec 5, 2025. The device falls under product code KXK (Source, Brachytherapy, Radionuclide), a Class II device regulated under 21 CFR 892.5730.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 5, 2025
Date Received
Jul 23, 2025
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Source, Brachytherapy, Radionuclide
Device Class
Class II
Regulation Number
892.5730
Review Panel
RA
Submission Type
510(k)

Need the full FDA record for Oncopatch, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K252296. Report a data issue: hello@regdatalab.com.